Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26F1PYX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,280.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12.28K to AmerisourceBergen Drug Corp for the supply of Kisqali 600 mg daily dose tablets (63-count units) on January 5, 2026, with completion scheduled for January 27, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999.999B through December 2026 and serves as the company's primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio under the DLA contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The current award demonstrates the company's continued capability to fulfill federal pharmaceutical supply requirements through open competition, reflecting its role as a key strategic partner in supporting military medical supply chains.
Quick answers
Who was awarded contract SPE2DR26F1PYX?
SPE2DR26F1PYX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F1PYX worth?
The government has obligated $12,280 on SPE2DR26F1PYX.
Is contract SPE2DR26F1PYX an order under another contract?
Yes. SPE2DR26F1PYX is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1PYX competed?
The extent of competition for SPE2DR26F1PYX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award